Tilray Brands, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Tilray Brands, Inc. (TLRY) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $31.70 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-28
- Tilray Brands, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-05-31 was $9.73M.
- Tilray Brands, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-02-28 was $9.18M, a 127.43% increase year-over-year.
- Tilray Brands, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-11-30 was $7.74M, a 6.90% increase year-over-year.
- Tilray Brands, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-08-31 was $5.05M, a 26.96% decline year-over-year.
- Tilray Brands, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2026 was $31.70M, a 30.51% increase from fiscal 2025.
- Tilray Brands, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $24.29M, a 23.54% decline from fiscal 2024.
- Tilray Brands, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $31.77M, a 19.77% decline from fiscal 2023.
- Tilray Brands, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $39.59M, a 10.00% increase from fiscal 2022.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|
| 2026-05-31 | $9.73M derived: 10-K 12 month − 3 quarters · filed 2026-07-28 | $18.91M derived: sum of 2 quarters · filed 2026-07-28 | $26.65M derived: sum of 3 quarters · filed 2026-07-28 | $31.70M 10-K · filed 2026-07-28 | |
| 2026-02-28 | $9.18M 10-Q · filed 2026-04-01 | $16.91M derived: sum of 2 quarters · filed 2026-04-01 | $21.96M derived: sum of 3 quarters · filed 2026-04-01 | ||
| 2025-11-30 | $7.74M 10-Q · filed 2026-04-01 | $12.79M derived: sum of 2 quarters · filed 2026-04-01 | |||
| 2025-08-31 | $5.05M 10-Q · filed 2026-04-01 | ||||
| 2025-05-31 | $24.29M 10-K · filed 2026-07-28 | ||||
| 2025-02-28 | $4.04M 10-Q · filed 2026-04-01 | $11.27M derived: sum of 2 quarters · filed 2026-04-01 | $18.19M derived: sum of 3 quarters · filed 2026-04-01 | ||
| 2024-11-30 | $7.24M 10-Q · filed 2026-04-01 | $14.15M derived: sum of 2 quarters · filed 2026-04-01 | |||
| 2024-08-31 | $6.92M 10-Q · filed 2026-04-01 | ||||
| 2024-05-31 | $31.77M 10-K · filed 2026-07-28 | ||||
| 2024-02-29 | $8.06M 10-Q · filed 2025-04-08 | $16.26M derived: sum of 2 quarters · filed 2025-04-08 | $24.52M derived: sum of 3 quarters · filed 2025-04-08 | ||
| 2023-11-30 | $8.20M 10-Q · filed 2025-04-08 | $16.46M derived: sum of 2 quarters · filed 2025-04-08 | |||
| 2023-08-31 | $8.26M 10-Q · filed 2025-04-08 | ||||
| 2023-05-31 | $39.59M 10-K · filed 2025-07-29 | ||||
| 2023-02-28 | $9.63M 10-Q · filed 2024-04-09 | $20.57M derived: sum of 2 quarters · filed 2024-04-09 | $29.77M derived: sum of 3 quarters · filed 2024-10-10 | ||
| 2022-11-30 | $10.94M 10-Q · filed 2024-04-09 | $20.14M derived: sum of 2 quarters · filed 2024-10-10 | |||
| 2022-08-31 | $9.19M 10-Q · filed 2024-10-10 | ||||
| 2022-05-31 | $35.99M 10-K · filed 2024-07-30 | ||||
| 2022-02-28 | $9.36M 10-Q · filed 2023-04-10 | $22.23M derived: sum of 2 quarters · filed 2023-04-10 | $31.65M derived: sum of 3 quarters · filed 2023-04-10 | ||
| 2021-11-30 | $12.88M 10-Q · filed 2023-04-10 | $4.05M 10-Q · filed 2022-01-10 | $22.29M derived: sum of 2 quarters · filed 2023-04-10 | ||
| 2021-08-31 | $9.42M 10-Q · filed 2023-04-10 | -$5.94M 10-Q · filed 2021-10-07 | |||
| 2021-05-31 | $19.39M 10-K · filed 2023-07-26 | ||||
| 2021-03-31 | $7.14M 10-Q · filed 2021-05-10 | ||||
| 2020-12-31 | $29.72M 10-K · filed 2021-02-19 | ||||
| 2020-11-30 | $1.02M 10-Q · filed 2022-01-10 | ||||
| 2020-09-30 | $8.08M 10-Q · filed 2020-11-09 | ||||
| 2020-08-31 | $1.23M 10-Q · filed 2022-01-10 | ||||
| 2020-06-30 | $7.65M 10-Q · filed 2020-11-09 | $15.32M derived: sum of 2 quarters · filed 2021-05-10 | |||
| 2020-05-31 | $18.08M 10-K · filed 2022-07-28 | ||||
| 2020-03-31 | $7.68M 10-Q · filed 2021-05-10 | ||||
| 2019-12-31 | $31.84M 10-K · filed 2021-02-19 | ||||
| 2019-09-30 | $8.64M 10-Q · filed 2020-11-09 | $8.31M 10-Q · filed 2019-11-13 | $16.57M derived: sum of 2 quarters · filed 2020-11-09 | $22.30M derived: sum of 3 quarters · filed 2020-11-09 | |
| 2019-06-30 | $7.92M 10-Q · filed 2020-11-09 | $7.58M 10-Q · filed 2019-08-13 | $13.66M derived: sum of 2 quarters · filed 2020-11-09 | ||
| 2019-05-31 | $29.03M 10-K · filed 2021-07-28 | ||||
| 2019-03-31 | $5.74M 10-Q · filed 2020-11-09 | $5.31M 10-Q · filed 2019-05-15 | |||
| 2018-12-31 | $20.99M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $11.24M 10-Q · filed 2019-11-13 | $16.85M derived: sum of 2 quarters · filed 2019-11-13 | $16.88M derived: sum of 3 quarters · filed 2019-11-13 | ||
| 2018-06-30 | $5.60M 10-Q · filed 2019-11-13 | $5.63M derived: sum of 2 quarters · filed 2019-11-13 | |||
| 2018-03-31 | $31.00K 10-Q · filed 2019-11-13 | ||||
| 2017-12-31 | $139.00K 10-K · filed 2020-03-02 | ||||
| 2016-12-31 | $94.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |